Quantitative determination of 4-hydroxy-4-androstene-3, 17-dione (4-oha), a potent aromatase inhibitor, in human plasma, using isotope dilution mass spectrometry
- 1 May 1989
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 32 (5) , 699-702
- https://doi.org/10.1016/0022-4731(89)90515-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Aromatase inhibitors: Basic and clinical studiesJournal of Steroid Biochemistry, 1987
- TREATMENT OF ADVANCED POSTMENOPAUSAL BREAST-CANCER WITH AN AROMATASE INHIBITOR, 4-HYDROXYANDROSTENEDIONE - PHASE-II REPORT1986
- Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the ratThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- Aromatase inhibitors and the treatment of breast cancerJournal of Steroid Biochemistry, 1986
- 4-HYDROXYANDROSTENEDIONE IN TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST CANCERThe Lancet, 1984
- Synthesis of deuterium- and tritium-labeled 4-hydroxyandrostene-3,17-dione, an aromatase inhibitor, and its metabolism in vitro and in vivo in the ratBiochemical Pharmacology, 1982
- Synthesis of C7-2H2 steroids for human metabolism studiesJournal of Labelled Compounds and Radiopharmaceuticals, 1978